Pharmafile Logo

Research Partnership is on the rise

December 21, 2021 | Mark Jeffrey, Pharma, global healthcare 

Research Partnership ranks 12th in fastest growing UK market research agency league  tables

The UK’s best performing market research agencies were revealed this week with the publication of Research Live’s Industry Report for 2021, which includes the latest Market Research Society (MRS) League Tables. Based on available 2020 financial data that was compiled and analysed in November 2021, the MRS league tables identify and rank the best-performing research agencies and businesses according to their UK-based turnover and by their year-on-year growth.

In a very challenging year globally, Research Partnership bucked the trend by achieving an impressive 21% growth against an industry average of 0.8%. Less than half of the top 100 companies reported any growth.

Research Partnership ranked 23rd in the top individual agencies with a confirmed turnover of £40.297m and remains the UK’s largest individual healthcare consulting specialist.

The company ranked 7th in the top 20 fastest-growing businesses and 12th in the top 20 fastest-growing individual agencies.

Joint Founding Director Mark Jeffery commented, “Research Partnership has achieved considerable growth in a very turbulent climate. Fortunately, we were able to pivot quickly to remote working using online methodologies and we responded effectively to increased demand from our clients. Last year, we continued our recruitment drive and increased our headcount from 216 to 250 with appointments made across the US, EU and APAC offices. We also continued to grow both our market research and market access services, and we are winning business from both new and existing clients across the pharmaceutical, medtech and biotech sectors. According to our customer survey, satisfaction with insights and recommendations remained high and we are still delivering the quality service expected of us.”

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Cool heads in a crisis?

Understanding the role pharmaceutical companies can play in fighting today’s global health pandemics

Biosimilars: Bringing patients into the conversation

Published in eyeforpharma January 2017 by Mariel Metcalfe

Access and elimination: the future of DAAs in hepatitis C

Published in Pharmaphorum January 2017

EphMRA One Day Meeting

We are delighted to be attending and presenting a paper at the EphMRA one day meeting on Tuesday 21st February, in London

Video: Segmentation research

Why would a pharma company want to carry out a segmentation study? What are some of the challenges? Head of Business Analytics Tom Nolte and Associate Director Dr Marianne Jaeger...

Pharmaceutical Market Research Conference 2017

We are delighted to be exhibiting and presenting a paper at the Pharmaceutical Market Research Conference 1-2 February in Parsippany, NJ.

Shifting perceptions of the use of probiotics in IBS Management

Our client was planning to launch an over-the-counter (OTC) probiotics product for the purposes of improving IBS management and wanted to understand current perceptions, practices and usage amoungst a range...

Nutraceuticals in India: A Challenging Opportunity

Published in eyeforpharma December 2016 by Marc Yates

Research Partnership makes annual donation to Forever Projects

Research Partnership has made a seasonal donation of US$5,000 to our chosen charity, Forever Projects

A Bitter Pill?

The ideal route of admin isn’t clear cut in the global marketplace